Latest immunotherapy news
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
posted July 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma Monthly Specialist Briefings
Stay Connected
